Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 2/20 | 0.64 |
| ▸ | RECQL | P46063 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.64 |
| ▸ | AURKA | O14965 | 1/20 | 0.64 |
| ▸ | NPC1 | O15118 | 1/20 | 0.64 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.64 |
| ▸ | JAK2 | O60674 | 1/20 | 0.64 |
| ▸ | STK17B | O94768 | 1/20 | 0.64 |
| ▸ | ALPL | P05186 | 1/20 | 0.64 |
| ▸ | ALPI | P09923 | 1/20 | 0.64 |
| ▸ | GAA | P10253 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.64 |
| ▸ | ALPG | P10696 | 1/20 | 0.64 |
| ▸ | CDK4 | P11802 | 1/20 | 0.64 |
| ▸ | MAOA | P21397 | 1/20 | 0.64 |
| ▸ | APEX1 | P27695 | 1/20 | 0.64 |
| ▸ | SYK | P43405 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6611437 | 1.00 | APP (1.00) | APPMEN1RECQLKMT2AKDM4E | |
| SCHEMBL30931489 | 1.00 | APP (1.00) | APPMEN1RECQLKMT2AKDM4E | |
| SCHEMBL6804252 | 0.90 | APP (0.81) | APP | |
| SCHEMBL6610772 | 0.90 | APP (0.81) | APP | |
| SCHEMBL6809397 | 0.87 | APP (0.76) | APP | |
| SCHEMBL6809399 | 0.87 | APP (0.76) | APP | |
| SCHEMBL6616200 | 0.86 | APP (0.76) | APP | |
| SCHEMBL6617139 | 0.86 | APP (0.76) | APP | |
| SCHEMBL6809225 | 0.86 | APP (0.76) | APP | |
| SCHEMBL6808400 | 0.86 | APP (0.76) | APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11712056-B2 | Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases | VALBIOTIS (FR) | 2023-08-01 | — | — | US | claimed |
| EP-3982924-B1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2023-07-26 | — | — | EP | claimed |
| US-20220257685-A1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2022-08-18 | — | — | US | claimed |
| EP-4039332-A1 | METHOD OF EXTRACTION AND ENRICHMENT OF MONOGLYCOSYLATED FLAVONOIDS FROM CHRYSANTHELLUM INDICUM FOR THE TREATMENT OF INFLAMMATORY-BASED POLYARTHRITIC DISORDERS, FOR USE IN COSMETIC, NUTRACEUTICAL AND MEDICAL DEVICES AND PHARMACEUTICAL APPLICATIONS | Phytoitalia SRL (IT) | 2022-08-10 | — | — | EP | claimed |
| EP-3533454-B1 | COMPOSITION COMPRISING A MIXTURE OF PLANT EXTRACTS OR A MIXTURE OF MOLECULES CONTAINED IN SAID PLANTS AND USE TO ACT ON THE CARBOHYDRATE AND/OR LIPID METABOLISM | VALBIOTIS (FR) | 2022-04-20 | — | — | EP | claimed |
| US-20040132807-A1 | Aurones as telomerase inhibitors | PHARMACIA ITALIA SPA (IT) | 2004-07-08 | — | — | US | claimed |
| EP-4362892-B1 | COMPOSITION COMPRISING AT LEAST ONE ALKYL (POLY)GLYCOSIDE, AT LEAST ONE FATTY ALCOHOL, AT LEAST ONE FATTY ACID, AND AT LEAST ONE ALKALINE AGENT | OREAL (FR) | 2026-04-15 | — | — | EP | disclosed |
| US-12533311-B2 | Method for dyeing keratin fibres starting from isatin and from powder and/or dye extract of indigo-producing plants | L'OREAL (FR) | 2026-01-27 | — | — | US | disclosed |
| US-20250387309-A1 | METHOD FOR THE TREATMENT OF KERATIN FIBRES COMPRISING A PRETREATMENT OR POST-TREATMENT STEP | OREAL (FR) | 2025-12-25 | — | — | US | disclosed |
| EP-4452203-B1 | PROCESS FOR DYEING KERATIN FIBRES USING A COSMETIC COMPOSITION COMPRISING PROPANE-1,3-DIOL AND A DYEING COMPOSITION | OREAL (FR) | 2025-12-24 | — | — | EP | disclosed |
| US-20250375366-A1 | PROCESS FOR TREATING KERATIN FIBRES USING A CARNITINE SALT OR A CARNITINE DERIVATIVE | OREAL (FR) | 2025-12-11 | — | — | US | disclosed |
| US-12472136-B2 | Composition comprising at least one alkyl (poly)glycoside, at least one fatty alcohol, at least one fatty acid, and at least one alkaline agent | L'OREAL (FR) | 2025-11-18 | — | — | US | disclosed |
| US-12453686-B2 | Cosmetic composition comprising at least one alkyl (poly)glycoside, N,N-dicarboxymethylglutamic acid, propane-1,3-diol, at least one fatty substance other than fatty acids, at least one dye | L'OREAL (FR) | 2025-10-28 | — | — | US | disclosed |
| US-20100267823-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-10-21 | — | — | US | disclosed |
| US-20100267822-A1 | AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-10-21 | — | — | US | disclosed |
| US-20100267823-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-10-21 | — | — | US | disclosed |
| US-20100267822-A1 | AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-10-21 | — | — | US | disclosed |
| WO-2010110647-A1 | AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-09-30 | — | — | WO | disclosed |
| WO-2010110646-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | BIOTROPICS MALAYSIA BERHAD (MY) | 2010-09-30 | — | — | WO | disclosed |
| US-20040132807-A1 | Aurones as telomerase inhibitors | PHARMACIA ITALIA SPA (IT) | 2004-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250375366-A1 | PROCESS FOR TREATING KERATIN FIBRES USING A CARNITINE SALT OR A CARNITINE DERIVATIVE | KRT18, CRAT, CKMT1A; CKMT1B | APP 2493/4885MEN1 2783/4885RECQL 4394/4885 |
| US-20100267822-A1 | AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES | SHBG, GPER1, ESR2 | APP 3806/4885MEN1 2779/4885RECQL 3283/4885 |
| US-20250387309-A1 | METHOD FOR THE TREATMENT OF KERATIN FIBRES COMPRISING A PRETREATMENT OR POST-TREATMENT STEP | PROC, KRT18, VCL | APP 3887/4885MEN1 4597/4885RECQL 4094/4885 |
| US-20040132807-A1 | Aurones as telomerase inhibitors | TERT, TERF2, TERF2IP | APP 3533/4885MEN1 1719/4885RECQL 426/4885 |
| US-12533311-B2 | Method for dyeing keratin fibres starting from isatin and from powder and/or dye extract of indigo-producing plants | KRT18, CUTA, KRTCAP2 | APP 669/4885MEN1 4820/4885RECQL 4293/4885 |
| US-20100267823-A1 | AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS | PDE12, PDE3A, PDE7A | APP 817/4885MEN1 2855/4885RECQL 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.